Download presentation
Presentation is loading. Please wait.
1
Glycogen Metabolism Storage and Mobilization of Glucose NUTR 543 – Advanced Nutritional Biochemistry David L. Gee, PhD Professor of Food Science and Nutrition Department of Health, Human Performance, and Nutrition Central Washington University
2
Glycogen Functions Liver –Buffer for regulating blood glucose levels Muscle –Store of glucose as a fuel for exercise high intensity exercise dependent on anaerobic glycolysis
3
Glycogen Synthesis Figure 12-2
4
Regulation of Glycogen Synthase Figure 12-4 Active/Inactive Forms –Active dephosphorylated –Inactive phosphorylated
5
Regulation of Glycogen Synthase Fasting Figure 12-4 Glucagon or epinephrine –G-protein linked receptors –increased [cAMP]
6
Regulation of Glycogen Synthase Fasting Figure 12-4 cAMP activates Protein Kinase A Protein kinase A phosphorylates and inactivates glycogen synthase Little glycogen synthesis during fasting
7
Regulation of Glycogen Synthase Feeding Figure 12-4 Insulin –Reduces [cAMP] Stimulates phosphodiesterase –Induces and activates protein phosphatase-1 Activates GS Feeding results in glycogen synthesis
8
Glycogen Degradation Glycogen Phosphorylase –Hydrolyzes glucose units from glycogen –Produces glucose-1-P Removal of branch points –Debranching enzyme complex Glucan transferase Alpha-1,6-glucosidase
9
Regulation of Glycogen Phosphorylase Fasting Figure 12-7 Glucagon or epinephrine –Increase [cAMP] –Activates Protein Kinase A –Phosphorylates and activates glycogen phosphorylase Fasting results in increased glycogenolysis
10
Regulation of Glycogen Phosphorylase Feeding Figure 12-7 Insulin –Reduces [cAMP] –Induces and activates Protein Phosphatase-1 –Inactivates Glycogen Phosphorylase Feeding results in decreased glycogenolysis
11
Allosteric Regulation of Glycogen Phosphorylase Table 12-1
12
Regulation of Glycogen Degradation during Exercise Figure 12-8
13
Coordinated Regulation of Glycogen Metabolism (Table 12-2)
14
Application: Pharmacological Agents for Diabetics Insulin –Mandatory for Type 1 diabetics –Used in Type 2 diabetics as oral medications become less effective Oral medications –Mechanisms Increase insulin production Improve insulin receptor sensitivity Inhibit gluconeogenesis Inhibit carbohydrate absorption
15
Sulfonylureas First widely used diabetic drug Stimulates endogenous release of insulin from pancreas –Direct action on ATP-K channel protein on beta-cells Short and longer acting forms –Glipizide (Glucotrol), glyburide (Diabeta), tolazamide (Tolinase) Side Effects –Hypoglycemia –Weight gain
16
Meglitinides Like sulfonylureas, stimulate pancreatic secretion of insulin –Short-acting: taken with meals Replaglinide (Prandin) Side Effects –Hypoglycemia –Weight gain
17
Biguanides Mechanism of action –Reduces gluconeogenesis (stimulates (?) Protein kinase A) –Decrease absorption of dietary CHO –Increase insulin sensitivity Metformin (Glucophage) (most widely used anti-diabetic drug) Side effects (not hypoglycemia) –Lactic acidosis Contraindicated in heart failure, liver and kidney disorders –Diarrhea Other facts –Only drug shown to reduced risk diabetes related heart disease –Derived from French lilac (known as useful for treating symptoms of diabetes)
18
Thiazolidinediones (TZDs) Mechanism of action –Binds to nuclear receptors that increase transcription of certain genes Decreased insulin resistance Leptin levels decreased (increased appetite) Rosiglitazone (Avandia) Side effects: edema, risk of hepatitis, increased heart disease risk (5/07 – FDA safety alert)
19
Incretin mimetic Incretins are GI hormones that increase insulin production Exenatide (39aa peptide from saliva of gila monster (lizard spit), synthesized) –50% homology with Glugacon-Like Peptide (GLP), an incretin that stimulates insulin production and inhibits glucagon production –Self-regulating: active only when during hyperglycemia –Appetite suppresent effect: gradual weight loss Side effects: –may increase hypoglycemic risk with sulfonylureas –must be injected 2x per day
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.